<?xml version="1.0" encoding="UTF-8"?>
<p>Also, Li et al. examined five children with COVID-19 (two patients treated with antiviral drugs and three patients did not receive antiviral therapy), indicating that antiviral agents did not change the outcome or the duration of hospital stay (
 <xref rid="B17" ref-type="bibr">17</xref>). Lim et al. presented a 54-year-old non-smoker woman with no medical history, in whom the viral load started to decline and symptoms started to alleviate gradually with the start of lopinavir/ritonavir treatment, and eventually, the patient was discharged. The researchers reported that it is not clear that the reduced burden of COVID-19 is due to the healing process or to the administration of anti-viral therapy (
 <xref rid="B18" ref-type="bibr">18</xref>). Furthermore, Han et al. and Zhang et al. reported complete recovery in one patient who had diabetes and was treated with oseltamivir/ganciclovir (
 <xref rid="B14" ref-type="bibr">14</xref>) and two patients treated with oseltamivir and arbidol (30), respectively.
</p>
